For beverage companies, this trend supports the incorporation of GLP-1-supporting ingredients into beverages that consumers already enjoy daily. Rachel Buss, vice president of strategic insights at Curion, Deerfield, Ill., notes that beyond off-label use, adopters have reported anecdotal changes
As weight changes, many patients find daily movement becomes more tolerable
As a registered dietitian who works with patients on GLP-1 medications, Ive seen firsthand how frustrating this can be
[1] Whilst Ozempic has demonstrated significant efficacy in glycaemic control and, in adults with type 2 diabetes and established cardiovascular disease, cardiovascular risk reduction, gastrointestinal side effects are amongst the most commonly reported adverse reactions
Oral rehydration solutions help replace lost fluids and electrolytes